Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction

Benson Chellakkan Selvanesan(The University of Texas MD Anderson Cancer Center), Geeta Upadhyay(University of Chicago)
Cancer Letters
February 16, 2023
10.1016/j.canlet.2023.216094
Cited by 4

Related Papers

Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
|Journal for ImmunoTherapy of Cancer|2020|28
NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models
|Cancers|2023|6
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
|bioRxiv (Cold Spring Harbor Laboratory)|2020|4